Statistics for Monopar Therapeutics (id:6082 MNPR)

Valuation metrics

Market cap

106.08M

Enterprise value

48.26M

Trailing P/E (ttm)

-6.59

Forward P/E

-8.52

PEG ratio

-8.52

Price/Sales (ttm)

Price/Book (mrq)

10.72

Enterprise Value/Revenue

Enterprise Value/EBITDA

-5.46

Overview

Shares outstanding

5.28M

Float

1.62M

Shares short

49.85K

% Held by insiders

0.43%

% Held by institutions

0.24%

Average volume (10 days)

105.03K

Average volume (90 days)

Price summary

52-Week low

1.37

52-Week high

38.50

52-Week change

92.34%

Beta

1.10

50-Day moving average

10.40

200-Day moving average

5.15

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

August 13th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-53.44%

Return on equity

-102.31%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-7,124,184.00

Diluted EPS (ttm)

-1.98

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

7.12M

Total cash per share (mrq)

2.02

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

659.00%

Book value per share (mrq)

1.88

Cash flow

Cash flow statement

-6,817,933.00

Levered free cash flow (LFCF)

-4,433,461.00